The increase in t-PrP in the plasma of CJD (sporadic, acquired and genetic) can be detected from the early stages and does not vary between different stages of the disease, making it potentially useful as an early diagnosis biomarker. The gene discussed is PRNP; the disease is Creutzfeldt Jacob disease.